GlaxoSmithKline PLC — Director's Dealing 2018

Mar 5, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7057G

GlaxoSmithKline PLC

05 March 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, GSK Consumer Healthcare

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

Following the vesting on 2 March 2018 of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award Plan, Mr McNamara will receive a cash payment of $684,709.84 less applicable tax withholding in respect of 18,967.031 notional ADSs.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$36.10	18,967.031

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2018-03-02

f)

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLELFBVXFBBBL